Celebrate 35 years of Technoclone and a Special Ceveron® s100 price

Posted: November 15, 2022

It’s Not Just Support. It’s Solutions.    JOIN DIAPHARMA AS WE CELEBRATE 35 YEARS OF TECHNOCLONE BY SAVING ON CEVERON® s100 35 years of our partner, Technoclone 🎈 35 days of celebration 🎉 From now through Sunday December 18th, 2022, get a special Ceveron® s100 celebration price – this very unique special offer is valid during the 35 days celebration promotion...Read More

Thank you for visiting us at The Liver Meeting®

Posted: November 11, 2022

It’s Not Just Support. It’s Solutions.    DIAPHARMA AND VLVbio THANK YOU! We enjoyed meeting so many of you in-person at the AASLD The Liver Meeting®, and sharing new studies using CK18/K18-M30® and CK18/K18-M65® as blood-based biomarkers in the world of NASH, acute alcohol-associated hepatitis, and DILI. DiaPharma has also added new and unique assay kits to assess liver injury ...Read More

Because matrix matters! The path to liver disease is paved with MMPs and collagen

Posted: November 11, 2022

It’s Not Just Support. It’s Solutions.    DiaPharma and QuickZyme Know Matrix Matters! Matrix Metalloproteases (MMPs) degrade collagen and elastin. As indicators of inflammation and disease, they are key targets for drug development. Biliary Atresia – MMP-7 has garnished much research support for its role in mediating biliary injury in the disease. NAFLD/NASH – Serum MM...Read More

What's New at DiaPharma?

Posted: November 9, 2022

It’s Not Just Support. It’s Solutions.    DiaPharma in the Community DiaPharma staff supports many impactful causes. DiaPharma and our staff proudly sponsor events close to our hearts and our community. Most recently, DiaPharma sponsored Ross’s Race in the Alzheimer’s Association Walk to End Alzheimer’s®, and the Circle Tail Golf Classic for Circle Tail assistance...Read More

DiaPharma has a lot to share at The Liver Meeting® - come see us!

Posted: October 27, 2022

It’s Not Just Support. It’s Solutions.    VISIT DIAPHARMA AND VLVbio AT THE LIVER MEETING®! A LOT has happened since the last in-person AASLD The Liver Meeting® and DiaPharma has a lot to share about new studies using CK18/K18-M30® and CK18/K18-M65® as blood-based biomarkers in the world of NASH, acute alcohol-associated hepatitis, and DILI. Booth # 712 is where Team DiaPharma ...Read More

Thank you for connecting with DiaPharma at Midwest Platelet!

Posted: October 20, 2022

It’s Not Just Support. It’s Solutions.   THANK YOU TO THOSE WHO CONNECTED WITH US AT THE MIDWEST PLATELET CONFERENCE DiaPharma is proud to celebrate 25 years in the hemostasis and coagulation business. Thank you to those who stopped by our booth at the Midwest Platelet Conference. We welcomed the opportunity to talk all things bleeding & clotting, and demo new technology for...Read More

Overworked staff? The T-TAS® 01 platelet function analyzer can lighten the burden

Posted: October 18, 2022

It’s Not Just Support. It’s Solutions. T-TAS® 01 PL Assay: One test, one result, one total answer for platelet function Help address staffing and budgetary challenges with a frontline test for overall total platelet function Single assay with easy-to-interpret test result provides simple and comprehensive platelet reactivity status Consolidate testing from multiple platforms, for ...Read More

Special Pricing on Non-Invasive, Non-Destructive Ecotoxicology Assays

Posted: October 11, 2022

It’s Not Just Support. It’s Solutions. Environmental Impact Matters. PERFORM ENDOCRINE DISRUPTOR STUDIES WITHOUT KILLING THE FISH NON-INVASIVE, EASY TO USE, ACCURATE ECOTOXICOLOGY ELISAs Contact your territory manager for special 4th quarter pricing on Vitellogenin ELISAs! Use TECO® Mucus Collection Swabs and test kits to test fish: follow individuals and populations over time e...Read More

Go further than FEV1 and FVC – Mechanistic Biomarkers for Lung Disease

Posted: October 11, 2022

It’s Not Just Support. It’s Solutions. A Case for Letting Endotype Lead the Way in Drug Development…   Neutrophilic      VS      Eosinophilic The molecular mechanisms that drive chronic lung disease are heterogenetic. To evolve past a “one drug fits all approach”, toward a more individualized and precision approach, pharmaceutical companies are focusing on drugs th...Read More

Clot Club #35

News and Events

Posted: October 7, 2022

THSNA 2022 RECAP ...Read More

Factor XIII Assays to Fit Your Needs

Posted: September 30, 2022

t’s Not Just Support. It’s Solutions. Factor XIII Activity Assays – The Right Fit for your Needs Manual and automated solutions for measuring FXIII Activity Technofluor® Factor XIII Fully automated on the Ceveron s100 for the determination of FXIII activity levels. Minimal hands-on time Data in under 30 minutes Single calibration per lot No need for blank samples Sensitive at...Read More

Endotyping for Clinical Trial Success with COPD, bronchiectasis, asthma

Posted: September 29, 2022

It’s Not Just Support. It’s Solutions. Endpoints for clinical trials in lung disease could be better… FEV1 and FVC are relatively blunt tools for getting a complete picture of a disease state – they do not provide information on the pulmonary microenvironment. Inflammation is a hallmark of chronic lung diseases and an important piece of the bigger picture to understand when...Read More

Measure fibrosis in a more meaningful way using TOTAL collagen assays

Posted: September 28, 2022

It’s Not Just Support. It’s Solutions. Let DiaPharma introduce you to a new partner in fibrosis research, QuickZyme Biosciences DiaPharma is excited to announce that we now offer QuickZyme products. QuickZyme knows, “Matrix Matters”. Collagens are a main component of the extracellular matrix and are the most abundant proteins in the body. Collagens play important roles in cell gr...Read More

Clot Club #34

News and Events

Posted: September 26, 2022

VACCINE-INDUCED THROMBOTIC THROMBOCYTOPENIA (VITT): INSIGHTS FROM ISTH 2022 ...Read More

AASLD The Liver Meeting™ 2022

Event Date: November 4 - 8, 2022

Event Location: Booth 712, Washington, DC

DiaPharma offers non-invasive biomarker tests for researching NASH, AH, DILI, and metabolic syndrome. Visit us and our VLVbio colleagues at booth 712 to discuss M30® and M65® Cytokeratin/Keratin 18 ELISAs for assessing hepatocyte apoptosis/necrosis, and explore our full portfolio of liver injury biomarkers. Research use only in U.S. and Canada. ...Read More

Tools for Sickle Cell Disease Research

Posted: September 22, 2022

It’s Not Just Support. It’s Solutions. Tools for Sickle Cell Disease Research September is National Sickle Cell Awareness Month. From Anti-Hemoglobin S antibodies, coagulation kits, and biomarker assays, to exciting new instrumentation for clotting analysis, DiaPharma has what matters covered for impactful Sickle Cell research. Research projects like gene therapy require many deci...Read More

18th Midwest Platelet Conference

Event Date: October 6 - 8, 2022

Event Location: University of Michigan, Ann Arbor, MI

...Read More

Time to include Human TSP2 in your next NASH study?

Posted: September 14, 2022

It’s Not Just Support. It’s Solutions.   Time to include Thrombospondin-2 in your next NASH study… Thrombospondin-2 has been identified by transcriptomics as an emerging NASH biomarker. Protein analysis shows that it has promise for use in studying NAFLD, NASH, metabolic disease, and diabetes. This Human TSP2 ELISA kit, from ImmunoDiagnostics, is proven reliable for clin...Read More

Clot Club #33

News and Events

Posted: August 31, 2022

EMERGING THERAPEUTIC TARGETS FOR HEREDITARY ANGIOEDEMA  ...Read More

Thank you for celebrating with DiaPharma!

Posted: August 25, 2022

It’s Not Just Support. It’s Solutions. THANK YOU TO THOSE WHO CELEBRATED WITH US AT THSNA 2022 DiaPharma is proud to celebrate 25 years in the hemostasis and coagulation business. Thank you to those who stopped by our booth at the Thrombosis and Hemostasis Summit of North America (THSNA) this year in Chicago, IL. We welcomed the opportunity to talk all things bleeding & clotting,...Read More